Immunology/Inflammation(免疫及炎症)
The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.
Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].
BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].
Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.
Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].
References
[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.
[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.
[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.
[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.
[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.
[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.
[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.
[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.
Products for Immunology/Inflammation
- 5-Lipoxygenase(10)
- Papain(1)
- PGDS(1)
- PGE synthase(24)
- SIKs(11)
- IκB/IKK(64)
- AP-1(6)
- KEAP1-Nrf2(65)
- NOD1(1)
- TLR(139)
- NF-κB(235)
- Interleukin Related(167)
- 15-lipoxygenase(2)
- Others(63)
- Aryl Hydrocarbon Receptor(35)
- CD73(14)
- Complement System(57)
- Galectin(12)
- IFNAR(25)
- NO Synthase(74)
- NOD-like Receptor (NLR)(50)
- STING(104)
- Reactive Oxygen Species(454)
- Apoptosis(780)
- FKBP(20)
- eNOS(5)
- iNOS(29)
- nNOS(20)
- Glutathione(55)
- Adaptive Immunity(209)
- Allergy(124)
- Arthritis(34)
- Autoimmunity(179)
- Gastric Disease(95)
- Immunosuppressants(37)
- Immunotherapeutics(4)
- Innate Immunity(560)
- Pulmonary Diseases(108)
- Reactive Nitrogen Species(50)
- Reactive Sulfur Species(28)
- Specialized Pro-Resolving Mediators(50)
- Cyclic GMP-AMP Synthase(2)
- BCL6(3)
- CD20(3)
- CD28(1)
- FAP(7)
- PSMA(7)
- Nuclear Factor of activated T Cells (NFAT)(1)
- Glycoprotein VI(1)
- Tim3(2)
- Hapten(1)
- Nectin-4(2)
- Cat.No. 产品名称 Information
-
GC15811
Nigericin sodium salt
尼日利亚菌素钠盐
尼杆菌素钠盐是一种来自湿地链霉菌的电中性K+/H+离子载体,它是一种亲脂性抗生素,可以选择性地导致钾从线粒体膜中流失。 -
GC17532
Pertussis Toxin
百日咳毒素
百日咳毒素是一种基于蛋白质的 AB5 型外毒素,由百日咳博德特氏菌产生,可引起百日咳。
-
GC17309
Withaferin A
醉茄素A
Withaferin A是一种甾体内酯,通常从冬虫夏草(Withania somnifera (L.) Dunal)中提取。 -
GC13292
EGTA
乙二醇双(2-氨基乙基醚)四乙酸
A chelating agent -
GC17574
BAPTA
1,2-双(2-氨基苯氧基)-乙烷-N,N,N`,N`-四乙酸
An extracellular calcium chelator -
GC16795
DCA
二氯乙酸钠
DCA 是癌细胞中的代谢调节剂';具有抗癌活性的线粒体。 DCA 抑制 PDHK,导致肿瘤微环境中的乳酸减少。 DCA 增加活性氧 (ROS) 生成并促进癌细胞凋亡。 DCA 也可作为 NKCC 抑制剂。 -
GC11664
YM 90709
5,6-二氢-2,3-二甲氧基-6,6-二甲基苯并[7,8]吲哚嗪并[2,3-B]喹喔啉
An IL-5 receptor antagonist -
GC16832
Suramin hexasodium salt
苏拉明钠; Suramin hexasodium salt
苏拉明六钠盐是一种具有多种生物活性的多磺化萘脲。 -
GC12567
TRIM
1-(2-三氟甲基苯基)咪唑
An inhibitor of nNOS and iNOS -
GC16831
Agmatine sulfate
胍基丁胺;硫酸胍基丁胺;硫酸鲱精胺;胍基丁胺硫酸盐
A polyamine metabolite -
GC15727
Aminoguanidine hydrochloride
氨基胍盐酸盐; Pimagedine hydrochloride; GER-11; Aminoguanidinium chloride
An iNOS inhibitor -
GC13575
Pyrrolidinedithiocarbamate ammonium
吡咯烷二硫代氨基甲酸铵; Ammonium pyrrolidinedithiocarbamate; PDTC ammonium; APDC
A potent and reversible NF-κB inhibitor with antioxidant properties -
GC16656
L-Canavanine sulfate
L-刀豆氨酸硫酸盐
L-Canavanine硫酸盐是诱导型NO合酶的选择性抑制剂。 -
GC12309
7-Nitroindazole
7-硝基吲唑
A non-selective inhibitor of NOS isoforms -
GC14851
Vidofludimus
维多氟拉迪莫,4sc-101; SC12267
An immunosuppressive drug that inhibits DHODH -
GC13926
BMS-345541(free base)
BMS-345541(free base) 是 IKK 催化亚基的选择性抑制剂 (IKK-2 IC50=0.3 μM, IKK-1 IC50=4 μM)。 BMS-345541(游离碱)结合在 IKK 的变构位点。
-
GC15586
AP1903
AP1903
A CID for FKBPF36V fusion proteins -
GC16368
Indole-3-carbinol
3-吲哚甲醇; I3C; 3-Indolemethanol
A natural phytochemical -
GC17995
Tacrolimus monohydrate
他克莫司一水合物; FK506 monohydrate; Fujimycin monohydrate; FR900506 monohydrate
他克莫司一水合物 (FK506 monohydrate) 是一种大环内酯,与 FK506 结合蛋白 (FKBP) 结合形成复合物并抑制钙调神经磷酸酶,从而抑制 T 淋巴细胞信号转导和 IL-2 转录。 -
GC13693
Omaveloxolone (RTA-408)
RTA 408
A synthetic triterpenoid that blocks Keap1/Nrf2 signaling -
GC11660
Nitisinone
尼替西农; NTBC; Nitisone; SC0735
An HPPD inhibitor -
GC11513
Zofenopril calcium
佐芬普利钙,SQ26991
A prodrug form of zofenoprilat -
GC18126
Balsalazide
巴柳氮
A prodrug form of 5-ASA -
GC16306
Dapsone
氨苯砜; 4,4′-Diaminodiphenyl sulfone; DDS
An anti-inflammatory, antimalarial, and antibacterial compound -
GC10210
VGX-1027
GIT 27
An immunomodulatory compound -
GC13066
Y-320
An inhibitor of IL-15-mediated CD4 T cell activation
-
GC10451
U-73122
1-[6-[((17Β)-3-雌酮-1,3,5[10]-三烯-17-基)氨基]乙基]-1H-吡咯-2,5-二酮
U-73122是有效的、选择性的磷脂酶C(PLC)抑制剂,IC50值约为1-2.1µM,也可抑制5-脂氧合酶(5-LO)。 -
GC18046
Erdosteine
厄多司坦; RV 144
A mucolytic agent and an antioxidant -
GC11702
DL-Carnitine HCl
混旋肉碱盐酸盐,DL-Carnitine chloride
DL-Carnitine HCl 存在两种异构体,称为 D 和 L。 -
GC15550
Lacidipine
拉西地平
An L-type calcium channel blocker -
GC14586
Efaproxiral Sodium
乙丙昔罗钠,RSR13 sodium
An allosteric hemoglobin modifier -
GC15320
Diacerein
双醋瑞因; Diacerhein; Diacetylrhein
A prodrug form of rhein -
GC11670
Pranoprofen
普拉洛芬
An NSAID and COX-1 inhibitor -
GC16921
Bromhexine HCl
盐酸溴己新
Bromhexine HCl 是一种有效且特异性的 TMPRSS2 蛋白酶抑制剂,IC50 为 0.75 μM。 -
GC11698
Valaciclovir HCl
盐酸伐昔洛韦; Valaciclovir hydrochloride
A prodrug of acyclovir -
GC13616
Sodium ascorbate
维生素C钠; Sodium ascorbate; Sodium L-ascorbate; Vitamin C sodium salt
抗坏血酸钠(Sodium L-ascorbate)是一种电子供体,是一种内源性抗氧化剂。抗坏血酸钠选择性抑制 Cav3.2 通道,IC50 为 6.5 μM.抗坏血酸钠也是一种胶原蛋白沉积增强剂和弹性生成抑制剂。 -
GC10933
Sodium 4-Aminosalicylate
对氨基水杨酸钠; 4-Aminosalicylic acid sodium salt dihydrate
4-氨基水杨酸钠(4-氨基水杨酸钠盐二水合物)是目前用于耐多药结核病的抗分枝杆菌药物之一。 -
GC12517
Sasapyrine
双水杨酸酯; Salicylsalicylic acid; Disalicylic acid
An NSAID and a prodrug form of salicylic acid -
GC17393
Pyridoxine HCl
吡哆醇盐酸盐; Pyridoxol hydrochloride; Vitamin B6 hydrochloride
A 4-methanol form of vitamin B6 -
GC12114
Oxaprozin
奥沙普秦; Oxaprozinum; Wy21743
An NSAID and COX inhibitor -
GC16641
ML130 (Nodinitib-1)
ML130; CID-1088438
A selective NOD1 inhibitor -
GC16007
Methylthiouracil
甲硫氧嘧啶; MTU
甲基硫氧嘧啶是一种抗甲状腺药物。 -
GC17830
IMD 0354
N-[3,5-双(三氟甲基)苯基]-5-氯-2-羟基苯甲酰胺,IKK2 Inhibitor V
An IKKβ (IKK2) inhibitor -
GC14622
Diclofenac Potassium
双氯芬酸钾
双氯芬酸钾是一种有效的非选择性抗炎剂,作为 COX 抑制剂,对人 COX-1 和 COX-2 在 CHO 细胞中的 IC50 分别为 4 和 1.3 nM ,对羊 COX- 的 IC50 分别为 5.1 和 0.84 μM。 1 和 COX-2,分别。 -
GC13502
Cysteamine HCl
半胱胺盐酸盐; 2-Aminoethanethiol hydrochloride; 2-Mercaptoethylamine hydrochloride
A radioprotective aminothiol -
GC15058
Benzydamine HCl
盐酸苄达明
An Analytical Reference Standard -
GC11707
L-Ascorbyl 6-palmitate
抗坏血酸棕榈酸酯; L-Ascorbic acid 6-hexadecanoate; 6-O-Palmitoyl-L-ascorbic acid
A lipophilic derivative of ascorbic acid with antioxidant and antiproliferative activities -
GC11443
Allylthiourea
烯丙基硫脲; Thiosinamine; N-Allylthiourea
烯丙基硫脲是一种选择性抑制氨氧化的代谢抑制剂。 -
GC14438
Suprofen
舒洛芬; TN-762
A non-selective NSAID -
GC12645
Imiquimod maleate
马来酸咪喹莫特; R 837 maleate
A TLR7 agonist